Blog

Dr. Papa on CAR T-Cell Therapy for Head and Neck Cancer – OncLive


OncLive

Dr. Papa on CAR T-Cell Therapy for Head and Neck Cancer
OncLive
CAR T-cell therapy has become a standard of care for patients with hematologic cancers, explains Papa. It is now attempting to be used for patients with head and neck cancer. Head and neck cancer is a solid tumor that poses many challenges to CAR T

and more »

2017-04-06 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.